ReCode Therapeutics Presents New Preclinical Data from mRNA-based Program for Cystic Fibrosis at the ATS 2022 International Conference

Study confirms the ability of ReCode’s Selective Organ Targeting (SORT) lipid nanoparticle (LNP) platform to deliver optimized, functional CFTR mRNA as an aerosol directly to specific cell targets Results show consistent rescue of CFTR function across multiple cystic fibrosis patient genotypes, including genotypes that do not respond to approved CFTR modulator treatments MENLO PARK, Calif. … [Read more…]

Lionheart Acquisition Corporation II Shareholders Approve Previously Announced Business Combination with MSP Recovery

LCAP shareholders have approved the previously announced business combination at the Special Meeting held on May 18, 2022 Transaction Expected to Close May 20, 2022 CORAL GABLES, Fla.–(BUSINESS WIRE)–Lionheart Acquisition Corporation II (Nasdaq: LCAPU, LCAP, LCAPW, “Lionheart” or “LCAP”), a publicly traded special purpose acquisition company, today announced that shareholders of record as of April … [Read more…]

neuro42 Licenses Robot from Johns Hopkins University

SAN FRANCISCO–(BUSINESS WIRE)–neuro42, Inc. (“neuro42” or the “Company”), a medical imaging, robotics, and AI technology company, today announced an exclusive licensing agreement with Johns Hopkins University (“Johns Hopkins”) for their MR compatible robot for head, neck and spine applications, with additional non-exclusive licenses for related technologies and patents. Developed by Dr. Dan Stoianovici, director of … [Read more…]

Cerebral President and CMO David Mou, MD, Named Chief Executive Officer as CEO Kyle Robertson Leaves Position

Chief Operating Officer Jessica Muse Assumes President Role for Company, Clinical Advisor Thomas Insel agrees to join Board SAN FRANCISCO–(BUSINESS WIRE)–#Cerebral–David Mou, MD MBA, the company’s President and Chief Medical Officer, has been named as Cerebral’s Chief Executive Officer. Cofounder Kyle Robertson leaves his position as CEO, effective immediately. “We thank Kyle for his service. … [Read more…]

CHD Files Comments with FCC Urging Accommodation of Millions of People Sickened by Wireless Radiation

WASHINGTON–(BUSINESS WIRE)–On May 16, Children’s Health Defense (CHD) and 50 other safe tech and health advocacy non-profits filed legal comments with the Federal Communications Commission (FCC) in response to the FCC’s request for comment on how to “prevent and eliminate digital discrimination.” The proceeding was required by the Infrastructure Investment and Jobs Act (“Infrastructure Act”) … [Read more…]

Global $10.84 Bn Antacids Markets, Analysis, & Forecasts 2016-2021, 2021-2026F, 2031F by Drug Class, Distribution Channel, Formulation Type – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Antacids Global Market Report 2022, By Drug Class, Distribution Channel, Formulation Type” report has been added to ResearchAndMarkets.com’s offering. The global antacids market is expected to grow from $8.60 billion in 2021 to $9.13 billion in 2022 at a compound annual growth rate (CAGR) of 6.1%. The market is expected to reach $10.84 … [Read more…]

Global Osteoporosis Drugs Market Report (2022 to 2027) – Featuring GlaxoSmithKline, Novartis International and Merck & Co Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Osteoporosis Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s offering. This latest research report provides a detailed analysis of Osteoporosis Drugs Industry. The global osteoporosis drugs market is projected to reach $16.43 Billion in 2027, from $12.01 Billion in 2021. … [Read more…]

Global Biologics Market Report 2022: A $540.66 Billion Market in 2026 – Leading Products & Services, Key Features & Differentiators, and Development Products – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biologics Global Market Report 2022: By Type, By Distribution, By Route, By Drug, By Mode” report has been added to ResearchAndMarkets.com’s offering. The global biologics market is expected to grow from $338.45 billion in 2021 to $382.04 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The market is expected … [Read more…]

Global $129+ Bn Cancer Biologics Market Research, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cancer biologics Global Market Report 2022: By Type, By Application, By Distribution” report has been added to ResearchAndMarkets.com’s offering. The global cancer biologics market is expected to grow from $76.46 billion in 2021 to $86.64 billion in 2022 at a compound annual growth rate (CAGR) of 13.3%. The market is expected to reach … [Read more…]

AdaptHealth to Participate in UBS Global Healthcare Conference 2022

PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President and Director, and Jason Clemens, CFO, will participate in a fireside chat at the UBS Global Healthcare Conference 2022 on Wednesday, … [Read more…]